Scarica l'app Stockscreener
22.49
3.31%
-0.77
Pre-mercato:
22.85
0.36
+1.60%
Zymeworks Inc. Borsa (ZYME) Ultime notizie
Citizens reiterates Zymeworks stock rating on ADC pipeline progress By Investing.com - Investing.com Canada
Zymeworks (ZYME) Unveils Promising Phase 1 Data for ZW191 in Ova - GuruFocus
Zymeworks reports phase 1 trial results for ovarian cancer drug By Investing.com - Investing.com South Africa
Zymeworks Inc. Reports Promising Phase 1 Results for ZW191 in Platinum-Resistant Ovarian Cancer Patients - Quiver Quantitative
Ovarian cancer study: 78.6% response in one group on Zymeworks' ZW191 - Stock Titan
Zymeworks Inc. (ZYME) reports Q1 loss, misses revenue estimates - MSN
ZYME Q1 2026 Earnings: Wider-than-Expected Loss as Clinical-Stage Biotech Continues R&D InvestmentQuarterly Financial Update - newsline.com
Truist assumes Zymeworks stock coverage with buy rating on royalty platform - Investing.com UK
Truist assumes Zymeworks stock coverage with buy rating on royalty platform By Investing.com - Investing.com India
Zymeworks stock drops 4.22% as Zymeworks Inc posts National Cancer Survivors Day tribute - Traders Union
Is Zymeworks’ ADC Progress And Buyback Plan Reframing The Investment Case For ZYME? - Sahm
A Look At Zymeworks (ZYME) Valuation After Recent Clinical And Regulatory Milestones - Sahm
Zymeworks stock price target maintained at $46 by H.C. Wainwright - Investing.com UK
Truist Securities initiates coverage of Zymeworks (ZYME) with buy recommendation - MSN
ZYME Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Zymeworks Inc stock (US98986T1088): upcoming Jefferies conference appearance in focus - AD HOC NEWS
ZYME News | ZYMEWORKS INC (NASDAQ:ZYME) - ChartMill
Zymeworks Inc stock (US98985W1080): investor focus on AACR data and sector backdrop - AD HOC NEWS
Zymeworks (ZYME) Shares Slip 2.4%, Testing Support Near $23.55Monthly Profile - thelegaladvocate.com
Zymeworks Inc. (ZYME) Faces Selling Pressure as Shares Dip 2.40% — Key Levels in FocusPut Call Ratio - thelegaladvocate.com
Zymeworks Inc. (ZYME) Edges Higher as Support Holds SteadyTWAP Entry - The Legal Advocate
Zymeworks Inc. (ZYME) is a Great Momentum Stock: Should You Buy? - MSN
Zymeworks Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Q3 2025 Zymeworks Inc Earnings Call Transcript - GuruFocus
Zymeworks Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
ZYME SEC FilingsZymeworks 10-K, 10-Q, 8-K Forms - Stock Titan
Zymeworks Inc. (ZYME) - Minichart
Breakeven Is Near for Zymeworks Inc. (NASDAQ:ZYME) - Moomoo
Zymeworks: Royalty-Backed Biotech Flywheel With Underappreciated ADC Optionality (ZYME) - Seeking Alpha
Zymeworks authorizes fresh $125M share buyback - MSN
Zymeworks Inc stock (US98985W1080): buyback plan and insider equity awards draw fresh attention - AD HOC NEWS
Zymeworks grants RSUs and options to EVP | ZYME Insider Trading - Stock Titan
Zymeworks (ZYME) EVP files Form 3 reporting no share ownership - Stock Titan
Rubric Capital, David Rosen disclose 9.49% stake in Zymeworks (ZYME) - Stock Titan
Vanguard Group Inc. Increases Position in Zymeworks Inc. $ZYME - MarketBeat
Zymeworks Authorizes 2026 Share Repurchase Program, Affirms Liquidity - TipRanks
Zymeworks authorizes $125 million share buyback program - Investing.com UK
Zymeworks authorizes $125 million share buyback program By Investing.com - Investing.com South Africa
Zymeworks Inc. announces an Equity Buyback for $125 million worth of its shares. - marketscreener.com
Zymeworks (NASDAQ: ZYME) launches $125M stock buyback and outlines runway - Stock Titan
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock - The Manila Times
Biotech Zymeworks lines up $125M for 2026 buyback program - Stock Titan
Zymeworks Inc.'s Equity Buyback announced on November 16, 2025, has expired with 4,197,553 shares, representing 5.62% for $102.3 million. - marketscreener.com
Zymeworks to present at three major investor conferences in May and June 2026 - Pluang
Zymeworks Announces Participation in Upcoming Investor Conferences - Koreabizwire
About Us | Cabling Installation & MaintenanceZymeworks Announces Participation in Upcoming Investor Conferences - FinancialContent
Zymeworks Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ZYME) 2026-05-12 - Seeking Alpha
Earnings call transcript: Zymeworks reports Q1 2026 revenue drop, outlines strategic advancements - Investing.com India
Earnings call transcript: Zymeworks reports Q1 2026 revenue drop, outlines strategic advancements By Investing.com - Investing.com Australia
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):